期刊文献+

提高缺血性卒中诊治新技术的水平

下载PDF
导出
摘要 “卒中的新技术”既包括卒中治疗的技术,也包括诊断、遗传或影像学技术;既包括全新的技术,也包括对既有技术的评估和再认识。其实,后者对临床更具指导意义。因为对既有技术再次评估,以使其获得最大效益、避免风险,远比发明一种全新的技术更简便和高效。因此,我们应加强对已有技术的新认识,为卒中的诊治提供更有意义的指导。
作者 鲁明
出处 《中国脑血管病杂志》 CAS 2011年第7期337-341,共5页 Chinese Journal of Cerebrovascular Diseases
  • 相关文献

参考文献34

  • 1Matarin M, Brown WM, Singleton A, et al. Whole ge- nome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21 [J]. Stroke,2008,39(5) : 1586-1589.
  • 2Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction [ J ]. Science, 2007,316 (5830) : 1491-1493.
  • 3Musunuru K, Post WS, Herzog W, et al. Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for in- creased vascular disease [ J ]. Circ Cardiovasc Genet, 2010,3(5) :445-453.
  • 4Seshadri S, Beiser A, Pikula A, et al. Parental occur- rence of stroke and risk of stroke in their children: the Framingham study [ J ]. Circulation, 2010, 121 ( 11 ) : 1304-1312.
  • 5Heneghan C, Tyndel S, Bankhead C, et al. Optimal load- ing dose for the initiation of warfarin: a systematic review [ J ]. BMC Cardiovasc Disord,2010,10 : 18.
  • 6The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med, 1995,333 (24) : 1581-1587.
  • 7Lees KR, Bluhmki E, yon Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials [ J ]. Lancet, 2010,375 (9727) : 1695-1703.
  • 8Shobha N, Buchan AM, Hill MD. Canadian Aheplase for Stroke Effectiveness Study (CASES). Thrombolysis at 3- 4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry [ J ]. Cerebrovasc Dis, 2011,31 ( 3 ) : 223 -228.
  • 9Brekenfeld C, Schroth G, Mattle HP, et al. Stent place- ment in acute cerebral artery occlusion: use of a self-ex- pandable intracranial stent for acute stroke treatment [ J ]. Stroke ,2009,40 ( 3 ) :847-852.
  • 10Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke : SARIS ( stent-assis- ted recanalization in acute ischemic stroke) [ J]. Stroke, 2009,40( 11 ) :3552-3556.

二级参考文献5

共引文献951

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部